ALT, a marker of hepatic inflammation and steatosis, was positively associated with suboptimal glycemic status, consistent with previous studies linking elevated ALT to insulin resistance, non-alcoholic fatty liver disease (NAFLD) and increased hepatic gluconeogenesis (29, 30). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.